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Abstract Bim protein is one of the BH3-only proteins, members
of the Bcl-2 family that have only one of the Bcl-2 homology
regions, BH3. BH3-only proteins are essential initiators of
apoptotic cell death. Thus far, three isoforms of Bim have been
reported, i.e. BimEL, BimL and BimS. Here we report the cloning
and characterization of six novel isoforms of human Bim,
designated as BimK1, K2, and L1^L4, which are generated by
alternative splicing. Unlike the three known isoforms, none of
these novel isoforms contained a C-terminal hydrophobic region.
Among the novel isoforms, only BimK1 and K2 contained a BH3
domain and were proapoptotic, although less potent than the
classical isoforms. These two isoforms localized, at least in part,
in mitochondria when transiently expressed in HeLa cells as a
green fluorescent protein-fused form. These results suggest that
the BH3 domain is necessary for induction of apoptosis and
mitochondrial localization but not sufficient for the full
proapoptotic activity. While the classical isoforms were always
predominantly expressed in transformed cells, expression profiles
of bim isoforms were highly variable among normal tissues at
least in humans, suggesting a tissue-specific transcriptional
regulation of bim. ß 2001 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Apoptosis or programmed cell death is a physiologic pro-
cess that is regulated by evolutionarily conserved genes. Cells
undergoing apoptosis exhibit certain morphological and bio-
chemical characteristics such as cell shrinkage, plasma mem-
brane blebbing, chromatin condensation and DNA fragmen-
tation. Apoptosis is critical for the development and the
maintenance of all metazoans. Thus, dysregulation of apopto-
sis can contribute to many major diseases including cancer,
autoimmune disorders and certain neurodegenerative diseases
[1]. Apoptotic signals are mainly transduced through two rel-
atively distinct pathways: the so-called ‘intrinsic’ pathway
mediated by mitochondria from which proapoptotic mole-
cules such as cytochrome c are released into the cytosol and
an ‘extrinsic’ pathway triggered by members of the tumor
necrosis factor (TNF) receptor superfamily such as Fas
(Apo-1/CD95) or TNF-K receptor [2].
One of the major components of cell death machinery is the
Bcl-2 family. To date, at least 20 members of this family have
been reported in mammals. Bcl-2 family proteins either reside
constitutively on the mitochondrial membrane or translocate
to mitochondria in response to apoptotic stimuli and regulate
the release of proapoptotic molecules from mitochondria.
Thus they work as important sensors for cell death signals
[3]. Despite structural similarity, members of the Bcl-2 protein
family have either an anti-apoptotic or proapoptotic function.
The proapoptotic Bcl-2 subfamily is further divided into two
groups. One includes ‘multi-domain’ or ‘Bax-like’ proteins
that have three Bcl-2 homology domains (BH1^3) and the
other includes ‘BH3-only’ proteins that share sequence homol-
ogy only within the BH3 domain [4]. At least nine mammalian
BH3-only family members (Bad, Bik, Blk, Hrk, Bid, Bim,
Noxa, PUMA, Bmf) have been identi¢ed. Bim was initially
isolated by screening a cDNA expression library with a Bcl-2
protein probe [5]. Three Bim isoforms have been reported and
designated as BimEL, BimL and BimS, all of which bind to
Bcl-2 and induce apoptosis, BimS being the most potent. The
biological importance of these molecules is underscored by the
analysis of Bim-de¢cient mice in which lymphoid, myeloid
and plasma cells accumulate and autoimmune kidney disease
is developed due to impaired apoptosis [6]. Furthermore, Bim
was recently reported to play an important role in neuronal
and hematopoietic cell death caused by trophic factor deriva-
tion [7^9].
Here we describe novel isoforms of human Bim and discuss
their functions, subcellular localizations and expression pro-
¢les.
2. Materials and methods
2.1. Isolation and expression plasmid construction of human Bim
isoforms
Polyadenylated RNAs from human tissues (Clontech) were reverse-
transcribed and cDNAs encoding Bim were ampli¢ed by the polymer-
ase chain reaction (PCR) using SuperScript One-Step reverse tran-
scription-PCR (RT-PCR) with Platinum Taq (Life Technologies,
Inc.) according to the manufacturer’s protocol. The primers used
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for the ampli¢cation were 5P-GGAATTCATGGCAAAGCAACC-
TTCTGA-3P and 5P-GCGTCGACTCAATGCATTCTCCACACC-3P
(EcoRI and SalI linker sequences are underlined). The ampli¢ed prod-
ucts were digested with EcoRI and SalI, gel-puri¢ed and subcloned
into pEGFP-C2 (Clontech). For the ampli¢cation of bid cDNA, the
primers 5P-CCATGGACTGTGAGGTCAAC-3P and 5P-GTCCATC-
CCATTTCTGGCTA-3P were used.
2.2. Cell cultures and transfections
The human embryonic kidney cell line 293 and human cervical
cancer cell line HeLa were maintained in Dulbecco’s modi¢ed Eagle’s
medium supplemented with 10% fetal calf serum, 100 U/ml penicillin
and 0.1 mg/ml streptomycin at 37‡C in a humidi¢ed atmosphere of
5% CO2. Cells were transfected with the plasmids described above
using E¡ectene reagent (Qiagen) according to the manufacturer’s pro-
tocol. Carbobenzoxy-VAD-£uoromethyl ketone (zVAD-fmk) (Peptide
Institute, Osaka, Japan) was added in some experiments to a ¢nal
concentration of 50 WM.
2.3. Confocal microscopy
At 24 h posttransfection, the cells growing on glass-bottomed cul-
ture dishes were stained with 250 nM of MitoTracker Red (Molecular
Probes) and £uorescent images were obtained using a confocal micro-
scope (Fluoview FV300, Olympus, Tokyo, Japan).
2.4. Immunoblotting
Immunoblot analysis was performed as described previously [10]. In
brief, 30 Wg of the cell lysate was subjected to SDS^PAGE and trans-
ferred onto a nitrocellulose membrane. The membrane was incubated
with rabbit anti-green £uorescent protein (GFP) polyclonal antibody
(MBL, Nagoya, Japan) followed by horseradish peroxidase-conju-
gated anti-rabbit immunoglobulins (Sigma). The proteins were visu-
alized by using enhanced chemiluminescence immunoblotting detec-
tion reagents (Amersham).
2.5. Luciferase assay
293 cells growing on six-well culture plates were cotransfected using
E¡ectene reagent with various combinations of the expression plas-
mids encoding isoforms of Bim fused with enhanced green £uorescent
protein (EGFP) and pGV-C2 (Wako Chemicals, Osaka, Japan) that
encodes luciferase. After 48 h, the cells were washed once with phos-
phate-bu¡ered saline to remove dead and £oating cells. They were
then harvested and subjected to luciferase assay as described previ-
ously [11].
2.6. Analysis of bim isoform expression pro¢les
Human bim cDNA was ampli¢ed by RT-PCR as described using
total RNA puri¢ed from a panel of cell lines and human tissues
(Ambion and Clontech). 1 Wl of logarithmically amplifying PCR prod-
uct was applied onto a DNA LabChip (Agilent Technologies) and
loaded into an Agilent 2100 bioanalyzer according to the manufac-
turer’s protocol. Data analysis was performed with Agilent 2100 bio-
analyzer software.
2.7. Real-time quantitative RT-PCR
To quantify the transcript of bim, bim cDNA was ampli¢ed by RT-
PCR using the reagents described above and primers 5P-TGATGT-
AAGTTCTGAGTGTG-3P and 5P-ACGTAACAGTCGTAAGATA-
A-3P. One-step RT-PCR was performed using a 7700 ABI PRISM
Sequence Detector System (Perkin Elmer-Applied Biosystems). To
normalize the expression of bim, the glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) housekeeping gene was also ampli¢ed, using
primers 5P-GAAGGTGAAGGTCGGAGT-3P and 5P-GAAGATGG-
TGATGGGATTTC-3P. Fluorogenic probes 5P-ACCTCCCTACAG-
ACAGAGCC-3P and 5P-CAAGCTTCCCGTTCTCAGCC-3P carrying
5P 6-carboxy-£uorescein as a reporter dye and 3P 6-carboxy-tetrameth-
yl-rhodamine as a quencher dye were used to detect the PCR product
of bim and GAPDH, respectively. In every experiment, GAPDH was
ampli¢ed using a series of dilutions of a known amount of the stan-
dard RNA supplied by Perkin Elmer to prepare a standard curve.
Data analysis was performed as described [12] with slight modi¢ca-
tion.
3. Results
3.1. Isolation of novel isoforms of human bim
In the course of obtaining cDNA for the entire coding
region of human Bim using RT-PCR, we observed multiple
ampli¢ed products, whereas a single product was obtained for
human cDNA encoding Bid, for which no isoforms have been
reported (Fig. 1A). This prompted us to sequence each prod-
uct to see if they contained novel isoforms. As a result, in
addition to the three known isoforms of bim (EL, L and S),
we have cloned six novel isoforms and designated them
bimK1, K2, and L1^L4 (Fig. 1B). Using the genome sequence
of bim provided by Celera Genomics, three unidenti¢ed exons
were discovered in the bim locus and all isoforms were con-
¢rmed to be produced by alternative splicing (Fig. 1C).
Among the novel isoforms, bimK1, K2, L1 and L3 contained
‘BH3-exon’. However, BimL1 and L3 proteins were not pre-
dicted to have the BH3 domain due to the frame shift that
occurred by the insertion of the nucleotides transcribed from a
novel exon (Fig. 1C,D). Thus, the K subgroup of Bim proteins
had the BH3 domain and the L subgroup did not. Unlike the
three isoforms reported previously, none of these novel iso-
forms had a hydrophobic region near the C-terminus. BimEL
and BimL are reported to bind to the LC8 dynein light chain
through the LC8-binding motif [13^15]. Among the novel iso-
forms, K1, K2, L1 and L2 had this motif.
3.2. Subcellular localizations of human Bim isoforms
To investigate the subcellular localizations of the Bim iso-
forms, expression plasmids encoding EGFP^Bim fusion pro-
teins were constructed. To con¢rm the proper expression of
each fusion protein, lysates obtained from transfected 293
cells were analyzed by immunoblotting using anti-GFP poly-
clonal antibody (Fig. 2). Proper-sized fusion proteins with
comparable expression levels were detected in all lysates.
This implies that there is no signi¢cant di¡erence in stability
among the Bim isoforms as a GFP-fused form. In HeLa cells,
BimEL mainly localized in mitochondria as shown by the co-
localization of green £uorescence with MitoTracker Red
staining, although a signi¢cant level of green £uorescence
was detected di¡usely throughout the cell including the nu-
C
Fig. 1. Isolation of novel isoforms of Bim. A: Identi¢cation of multiple RT-PCR products of human bim. The coding region of human bim or
bid cDNA was ampli¢ed by RT-PCR using polyA RNA from human fetal liver (lanes 1, 4), brain (lane 2) and lung (lane 3). The PCR prod-
ucts were subjected to agarose gel electrophoresis and photographed. B: A representative pattern of the bim expression pro¢le. The RT-PCR
products of human bim obtained using total RNA from the KB cell line (solid line) or testis (broken line) were analyzed with an Agilent 2100
bioanalyzer. The names of the isoforms and the lengths of the RT-PCR products in base pairs are indicated. C: Genomic organization of hu-
man bim. The human bim locus based on the Celera database is shown at the top. The lengths of variously shaded exons are indicated below
in base pairs. The Bim isoforms are schematically depicted at the bottom with their lengths in number of amino acid residues. Arrows indicate
the positions of the stop codons. D: Amino acid sequence alignment of human Bim isoforms. The dynein-binding motif, BH3 domain and hy-
drophobic tail are boxed. Amino acid residues are numbered to the left of each sequence. Dotted lines indicate gaps in the sequence for opti-
mal alignment. The sequences frame-shifted from the previously reported isoforms are italicized. The C-termini of the isoforms are denoted by
asterisks.
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cleus (Fig. 3). MitoTracker Red staining was weaker in the
cells expressing BimEL. Since the uptake of MitoTracker is
dependent on the mitochondrial membrane potential (v8m),
BimEL was suggested to reduce v8m, which is an early event
of apoptosis. In this experiment, zVAD-fmk, a caspase inhib-
itor with a broad spectrum, was added to the culture just after
the liposome treatment to prevent cell loss by apoptosis.
Therefore, the reduction of v8m was not expected to be a
consequence of caspase activation. In addition, in cells ex-
pressing BimEL, mitochondria were recruited to the perinu-
clear region. The subcellular localization of BimL and BimS
was similar, but somewhat di¡erent from that of BimEL, as a
signi¢cant fraction of cells showed a homogeneous distribu-
tion of these isoforms throughout the cell. Other cells showed
a punctate pattern of distribution in the perinuclear region
where they colocalized with mitochondria as shown in
BimEL-expressing cells. Furthermore, mitochondrial staining
with MitoTracker Red was almost absent in some cells ex-
pressing these isoforms indicating the complete disruption of
v8m. This is consistent with the observation that BimL and
BimS are more potent inducers of cell death than BimEL [5].
The K subgroup of Bim isoforms showed a similar intracel-
lular distribution to BimEL. In contrast, the L subgroup of
Bim isoforms localized homogeneously both in the cytoplasm
and in the nucleus. None of the cells showed a mitochondrial
distribution or a reduction of MitoTracker staining, which
indicates that these isoforms are de¢cient in cell death-induc-
ing activities.
3.3. Proapoptotic functions of the novel isoforms
To investigate the Bim-mediated cell death more quantita-
tively, we measured luciferase activities of lysates obtained
from 293 cells cotransfected with a GFP^Bim expression plas-
mid and a luciferase vector (Fig. 4A). In this assay, luciferase
activities represent the relative cell numbers remaining in the
Fig. 2. Expression of EGFP^Bim fusion proteins. 293 cells were
transfected with 2 Wg of the EGFP^Bim constructs in the presence
of 50 WM of zVAD-fmk. Cells were harvested at 24 h after transfec-
tion and subjected to SDS^PAGE followed by immunoblotting. The
expressed proteins are indicated at the top of each panel. The faint
band comigrating with EGFP^BimL, detected when transfected with
pEGFP-BimEL (lane 1, arrow), is presumably due to the alternative
splicing that occurred between the donor and acceptor sites within
BimEL cDNA to generate BimL mRNA.
Table 1
The expression pro¢les of human bim isoforms in various tissues and cell lines
Tissue or cell linea Total bim expressionb bim isoformsc
EL L S K1 K2 L1 L2 L3 L4
Brain 1.6 36.7 13.2 18.3 5.8 9.5 5.9 2.1 5.3 3.4
Thymus 18.0 31.6 18.6 4.9 0.9 4.1 24.3 5.2 9.6 0.8
Heart 0.9 21.3 24.0 30.4 0.8 7.5 3.5 1.8 4.8 6.2
Trachea 17.2 37.6 13.6 7.3 1.1 5.7 21.0 3.4 9.0 1.3
Lung 29.9 42.5 24.7 4.7 0.7 5.3 8.2 1.8 11.2 0.9
Liver 4.8 15.3 23.5 29.0 0.3 5.9 3.9 1.3 17.7 3.4
Kidney 20.2 33.2 18.9 25.3 2.5 5.5 3.0 2.0 6.5 3.3
Spleen 14.2 36.0 25.9 18.7 1.7 4.1 1.9 4.6 3.3 4.1
Ovary 10.4 37.0 25.7 18.1 1.8 4.4 1.9 4.6 2.5 4.0
Testis 17.2 16.9 21.9 16.8 3.7 24.2 1.7 2.7 7.2 5.0
T98G 1.7 31.7 26.4 24.0 1.8 6.6 1.2 1.0 3.9 3.4
TGW 3.7 43.5 18.7 12.4 4.6 6.5 0.8 4.8 5.3 3.4
Y79 4.8 34.2 19.3 19.5 2.0 4.9 6.0 3.6 4.0 6.5
KB 1.2 37.4 20.4 24.4 1.4 4.7 1.8 2.3 3.2 4.4
MRC5 0.1 39.0 18.4 23.0 4.6 3.9 0.0 2.3 3.9 4.9
MCF7 20.2 41.6 18.5 19.2 0.8 5.3 4.4 1.1 7.7 1.4
HepG2 11.8 49.5 19.6 15.7 1.6 6.0 1.2 2.4 1.7 2.3
293 24.0 43.0 14.0 20.6 2.4 6.6 1.3 3.4 4.6 4.1
G401 2.8 34.7 18.7 22.3 4.8 7.6 0.8 2.6 5.0 3.5
HeLa 12.3 53.8 11.2 17.3 4.5 2.3 0.0 4.1 3.5 3.3
SCMC-ES-2 0.3 35.8 17.5 24.1 5.4 5.5 0.0 2.6 5.1 4.1
HOS 5.7 41.5 12.6 21.8 2.4 9.1 3.1 2.1 3.8 3.6
G292 2.4 42.1 19.2 14.8 3.1 5.4 1.5 4.5 2.6 6.8
MG63 0.3 30.1 20.0 25.4 2.5 4.7 0.0 3.5 4.3 9.5
Saos-2 6.7 49.4 16.0 15.6 2.1 5.7 2.9 3.2 2.6 2.5
697 11.1 29.5 21.6 25.1 4.7 8.4 6.1 0.8 2.9 0.9
Jurkat 3.8 36.4 30.1 11.2 1.6 8.0 6.6 2.1 1.5 2.6
aT98G, glioblastoma; TGW, neuroblastoma; Y79, retinoblastoma; KB, oropharyngeal epidermoid carcinoma; MRC-5, lung ¢broblast; MCF7,
breast cancer; HepG2, hepatoblastoma; 293, embryonic kidney; G401, Wilms’ tumor; HeLa, cervical carcinoma; SCMC-ES-2, Ewing’s sarco-
ma; HOS, osteosarcoma; G292, osteosarcoma; MG63, osteosarcoma; Saos-2, osteosarcoma; 697, pre-B cell leukemia; Jurkat, T cell leukemia.
bHuman bim cDNA ampli¢ed by RT-PCR was analyzed with a 7700 ABI PRISM Sequence Detector System. The expression of bim normal-
ized by GAPDH was shown as U103 copies/Wg total RNA. The analysis was performed in triplicate.
cHuman bim cDNA ampli¢ed by RT-PCR was analyzed with an Agilent 2100 bioanalyzer. The percentage of each isoform based on molarity
is presented. The value is the mean calculated from at least two independent RT-PCRs.
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Fig. 3. Subcellular localization of Bim isoforms. 293 cells were transiently transfected with EGFP^Bim constructs as indicated below the images
in the presence of 50 WM of zVAD-fmk. At 24 h after transfection, cells were stained with MitoTracker Red and £uorescence images were tak-
en using a confocal microscope. Images in the middle row show MitoTracker Red £uorescence. Merged pictures are shown in the right row.
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culture after the transfection. A marked decrease in luciferase
activity was observed when cells were transfected with the
classical three isoforms, i.e. the activity was 4^11% of that
obtained when transfected with GFP non-fusion protein. As
reported [5], BimS was the most potent inducer of cell death.
A moderate, but signi¢cant decrease (41^44% of GFP non-
fusion protein) was observed after the transfection with the K
subgroup of isoforms. In contrast, the L subgroup of isoforms
had a level of luciferase activity comparable to that of GFP
non-fusion protein, indicating that these isoforms do not
cause cell death.
Next, we tested the possibility that the L subgroup of iso-
forms which have no proapoptotic activity functions as a
dominant negative inhibitor of the classical isoforms. In this
experiment, 293 cells were cotransfected with various combi-
nations of EGFP^Bim plasmids together with a luciferase
vector. As shown in Fig. 4B, none of the L isoforms inhibited
the cell death caused by the classical isoforms in a dominant
negative manner.
3.4. Expression pro¢les of nine isoforms of bim in various
tissues and cell lines
Since some isoforms are comprised of similar numbers of
amino acid residues (i.e. L, L1 and L2 isoforms or S and K2
isoforms) and are phosphorylated under certain circumstances
[8], it is expected to be impossible to analyze expression pro-
¢les by immunoblotting. Therefore, to determine the mRNA
expression pro¢les of the bim isoforms, RT-PCR was per-
formed using total RNA from a panel of tissues and cell lines,
and pro¢les were analyzed with a 7700 ABI PRISM Sequence
Detector System or an Agilent 2100 bioanalyzer. As shown in
Table 1, the expression levels of total bim RNA were variable
among human tissues. The brain, heart and liver showed very
low levels of expression. Expression pro¢les of the bim iso-
forms were also highly variable among tissues. The classical
isoforms were generally abundantly expressed. However, the
percent expression of bimS was much lower in the thymus,
trachea and lung (4.7^7.3) than in other tissues (16.8^30.4).
In addition, bimK2 and L3 were highly expressed in the testis
and liver, respectively (24.2 and 17.7), whereas L1 expression
was higher in the thymus and trachea (24.3 and 21.0). In
contrast, regardless of the total level of bim expression, the
expression pro¢les in cancer or transformed cell lines were
rather uniform with the three classical isoforms being the
major forms. The percent expression of bimEL ranged from
29.5 to 49.5, that of bimL from 11.2 to 30.1 and that of bimS
from 11.2 to 25.4. All other isoforms were expressed at less
than 10%. As far as we examined, cell lines did not re£ect the
expression pro¢les of their parental normal tissues.
4. Discussion
To our knowledge, among BH3-only Bcl-2 family members,
Bim and PUMA (p53 upregulated modulator of apoptosis)
are known to have isoforms due to alternative splicing
[5,16]. In this study, we have identi¢ed and characterized six
novel isoforms of Bim. Our results are summarized in Table 2.
Fig. 4. Comparison of cell loss mediated by Bim isoforms. A: 293
cells were transfected with 1.5 Wg of plasmid encoding the isoforms
of Bim fused to EGFP in combination with 0.5 Wg of luciferase
plasmid. Cotransfection with plasmids encoding EGFP non-fusion
protein and luciferase was included as a control (GFP). Cells were
harvested 48 h after transfection and luciferase activities were mea-
sured. Data are presented as the mean þ standard error obtained
from at least three independent experiments performed in triplicate.
*P6 0.01 (vs. GFP by t test) B: 293 cells were transfected with var-
ious combinations of EGFP^Bim plasmids (0.9 Wg) as indicated at
the bottom along with luciferase plasmid (0.3 Wg). Luciferase activ-
ity was measured as in A. A plasmid encoding EGFP non-fusion
protein (GFP) was used to adjust the total amount of transfected
DNA. Data are presented similarly as in A.
Table 2
Summary of structure^distribution and structure^function relationship
Bim isoform BimEL BimL BimS BimK1 BimK2 BimL1 BimL2 BimL3 BimL4
BH3 + + + + + 3 3 3 3
Hydrophobic region + + + 3 3 3 3 3 3
Dynein-binding motif + + 3 + + + + 3 3
Mitochondrial distributiona ++ + + ++ þ 3 3 3 3
Reduced v8bm + ++ ++ + + 3 3 3 3
Cell deathc ++ ++ ++ + + 3 3 3 3
a;b++: more than 90% of the transfected cells fall into this category, +: 20^90% of the transfected cells fall into this category, þ : less than
20% of the transfected cells fall into this category, 3 : none of the transfected cells fall into this category.
cBased on Fig. 4A.
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Among Bim isoforms, only those that have the BH3 domain
showed proapoptotic activity. However, cell death-inducing
activities of the K subgroup of isoforms were much weaker
than those of the classical isoforms, suggesting that the BH3
domain is necessary but not su⁄cient for the induction of cell
death. It is likely that the C-terminal hydrophobic region is
required for the full activity of Bim. In contrast, the BH3
domain was su⁄cient for Bim to localize in mitochondria,
as we found the K subgroup successfully distributed in mito-
chondria. Since the BH3 domain is responsible for the binding
to anti-apoptotic Bcl-2 family members such as Bcl-xL, these
¢ndings imply that this binding but not membrane anchoring
plays an important role in the mitochondrial localization. The
failure of the L subgroup isoforms to act as a dominant neg-
ative molecule of the classical isoforms suggests that L sub-
group does not inhibit the classical forms from binding to
anti-apoptotic Bcl-2 family proteins.
BimEL and BimL are reported to interact with the LC8
cytoplasmic dynein light chain in healthy cells and, during
induction of apoptosis, are released together with LC8 from
the dynein motor complex and translocate to mitochondria
[13]. The Bim^LC8 interaction is mediated by the LC8-bind-
ing motif, KXTQT [13^15]. Although a typical punctate or
vesicular distribution, which is indicative of the cytoplasmic
dynein distribution in interphase cells [17^19], was not dem-
onstrated in the cells transfected with the isoforms containing
the LC8-binding motif, some of the molecules distributed in
the cytosol may bind to LC8. Interestingly, the BH3-contain-
ing isoforms partially colocalized with mitochondria simply
by overexpression. Overexpression of the proapoptotic Bim
isoforms or liposome-mediated transfection itself may be suf-
¢cient to trigger apoptotic signaling which leads to the disso-
ciation of the Bim protein from the dynein complex and the
translocation to mitochondria.
bim RNA was widely expressed in human tissues as re-
ported earlier [20]. A low expression in the brain, heart and
liver may re£ect a low turnover rate of these tissues due to a
suppressed apoptosis. Interestingly, unlike tumor or trans-
formed cells that showed rather uniform pro¢les of isoform
expression, highly variable pro¢les were observed in normal
tissues, suggesting a tissue-speci¢c transcriptional regulation
of the bim isoforms. Based on our ¢ndings that some isoforms
of Bim have proapoptotic activity to some degree and others
do not, the regulation of the expression of bim isoforms may
¢ne-tune the proapoptotic activity of Bim, resulting in either
an ampli¢cation or inhibition of the apoptotic response of
tissues or cells.
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